"This third IDMC recommendation represents a major milestone reaffirming the safety and progress of Bersiporocin," said Seong ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

Ingelheim, GermanyApproval is based on results from Phase III FIBRONEER™-IPF trial, which showed statistically significant improvements in the ...

The investigators hypothesized that AFM might be able to identify unique nanomechanical fingerprints (NMFs) in tissue samples ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis ...

Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the ...

First New Pulmonary Fibrosis Drug in a Decade Clinical trials show 38% slower lung function decline; Boehringer Ingelheim calls it a breakthrough ...

Avalyn will present four posters in conjunction with the PFF Summit 2025 Welcome Reception from 5-8 p.m. CT on Thursday, November 13, 2025.